CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors

Background While cancer vaccines have demonstrated promising clinical potential, their therapeutic efficacy against advanced tumors remains suboptimal, highlighting the critical need to elucidate resistance mechanisms and develop targeted solutions. We previously developed a stimulator of interferon...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Miaomiao Yang, Min Luo, Mengyan Wang, Yuwei Li, Zhigang Lu, Xianglei Wang, Shiyao Xue, Haotian Yu, Suxin Li
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2026-01-01
Saila:	Journal for ImmunoTherapy of Cancer
Sarrera elektronikoa:	https://jitc.bmj.com/content/14/1/e013336.full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!